India to Russia: Paclitaxel Export Trade Route

The India to Russia Paclitaxel corridor is one of India's established pharmaceutical export routes, with 69 shipments documented worth a combined $5.9M USD. The route is dominated by JODAS EXPOIM PRIVATE LIMITED, which alone accounts for roughly 48% of all export value, reflecting the consolidated nature of India's paclitaxel manufacturing sector.

Across 12 active suppliers, the average shipment value stands at $84.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with paclitaxel's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 33.7%, placing it at rank #12 among India's top paclitaxel export destinations globally.

On the import side, key buyers of Indian paclitaxel in Russia include OOO"JODAS EXPOIM" , OOOJODAS EXPOIM, OOO"JODAS EXPOIM" and 13 others. OOO"JODAS EXPOIM" is the single largest importer with 7 shipments valued at $1.9M USD.

India's paclitaxel exports to Russia are driven primarily by a handful of large-scale manufacturers. JODAS EXPOIM PRIVATE LIMITED with 26 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 12 active exporters signals a competitive but concentrated market — buyers in Russia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — JODAS EXPOIM PRIVATE LIMITED, JODAS EXPOIM PRIVATE LIMITED , RR PHARMACEUTICALS PRIVATE LIMITED — together account for 97% of total trade value on this route. The average shipment value of $84.8K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as paclitaxel concentrate for preparation of solution for infusion 6mg/ml-300mg/50ml as per document and paclitaxel concentrate for preparation of solution for infusion 6mg ml 300mg 50ml vial 5640 vials, suggesting that buyers in Russia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, OOO"JODAS EXPOIM" is the largest importer with 7 shipments worth $1.9M USD — representing 33% of all paclitaxel imports from India on this route. A total of 16 buyers are active on this corridor.